Cargando…
MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway
BACKGROUND: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. The dismal outcome of ICC patients is due to lack of early diagnosis, the aggressive biological behavior of ICC and the lack of effective therapeutic options. Early diagnosis and prognosis of ICC by non...
Autores principales: | Li, Jian-Hui, Zhu, Xiao-Xu, Li, Fu-Xi, Huang, Chen-Song, Huang, Xi-Tai, Wang, Jie-Qin, Gao, Zhuo-Xing, Li, Shi-Jin, Xu, Qiong-Cong, Zhao, Wei, Yin, Xiao-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882185/ https://www.ncbi.nlm.nih.gov/pubmed/31775892 http://dx.doi.org/10.1186/s13046-019-1477-4 |
Ejemplares similares
-
Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
por: Chen, Hua-Dong, et al.
Publicado: (2020) -
METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner
por: Xu, Qiong-Cong, et al.
Publicado: (2022) -
The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
por: Zhou, Qi, et al.
Publicado: (2013) -
CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
por: Mancarella, Serena, et al.
Publicado: (2022) -
Correction: CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype
por: Mancarella, Serena, et al.
Publicado: (2023)